{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:47:47Z","timestamp":1755218867879,"version":"3.43.0"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/ http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Introduction and importance:<\/jats:title>\n            <jats:p>Bouveret Syndrome (BS) is a rare type of gallstone ileus, where a gallstone passes via a cholecystoduodenal fistula and causes gastric outlet obstruction. It comprises 0.3\u20130.5% of cholelithiasis complications. It primarily affects females with an average incidence age of 74 years. Gastric Neuroendocrine Tumors (G-NETs) make up merely 2% of all forms of gastric neoplasia and are known to be an extremely rare occurrence. Their annual incidence is estimated to be one to two per 1 million individuals, and they comprise 8.7% of all known neuroendocrine neoplasia of the gastrointestinal system.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Case presentation:<\/jats:title>\n            <jats:p>We present the case of a 44-year-old Middle Eastern female who presented to the clinic due to multiple episodes of food containing biliary nonprojectile emesis accompanied by epigastric pain. Preoperative radiological workup revealed a Bezoar blocking the gastric outlet and a G-NET in the mucosal layer of the stomach.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Clinical discussion:<\/jats:title>\n            <jats:p>Surgical intervention consisted of excising the impacted calculus to relieve the existing gastric outlet obstruction simultaneous to performing an uncut Roux-en-Y to treat the G-NET condition. The patient underwent complete recovery.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>BS is an extremely rare form of gallstone ileus and gastric outlet obstruction. Its clinical presentation is nonspecific and results in misdiagnosis. Additionally, it is rare to occur in our patient\u2019s age group. NETs are also profoundly rare forms of neoplasia. To the best of our knowledge, no previous cases of simultaneous BS and G-NET have been documented. Therefore, clinical awareness should be raised to timely implement the necessary therapeutic interventions.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ms9.0000000000000459","type":"journal-article","created":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T05:00:52Z","timestamp":1681189252000},"page":"1206-1212","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Bouveret Syndrome simultaneous with an incidental solitary Gastric Neuroendocrine Tumor in a 44-year-old female - A Case Report"],"prefix":"10.1097","volume":"85","author":[{"given":"Jack","family":"Shaheen","sequence":"first","affiliation":[{"name":"Department of Surgery, Al Assad University Hospital"},{"name":"Department of Surgery, Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0292-0287","authenticated-orcid":false,"given":"Omar","family":"Al Laham","sequence":"additional","affiliation":[{"name":"Department of Surgery, Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zein","family":"Ibrahim Basha","sequence":"additional","affiliation":[{"name":"Department of Pathology, Al Assad University Hospital"},{"name":"Department of Pathology, Faculty of Medicine, Damascus University, Damascus, (The) Syrian Arab Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fareed","family":"Atia","sequence":"additional","affiliation":[{"name":"Department of Surgery, Al Assad University Hospital"},{"name":"Department of Surgery, Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7289-2923","authenticated-orcid":false,"given":"Rahaf","family":"Sharaf Aldeen","sequence":"additional","affiliation":[{"name":"Department of Surgery, Al Assad University Hospital"},{"name":"Department of Surgery, Al-Mouwasat University Hospital"},{"name":"Department of Surgery, Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Isaac","sequence":"additional","affiliation":[{"name":"Department of Surgery, Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alaa","family":"Alhanwt","sequence":"additional","affiliation":[{"name":"Department of Surgery, Al Assad University Hospital"},{"name":"Department of Surgery, Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2023,4]]},"reference":[{"key":"R1-20250806","doi-asserted-by":"crossref","first-page":"914951","DOI":"10.1155\/2009\/914951","article-title":"Bouveret\u2019s syndrome: case report and review of the literature","volume":"2009","author":"Doycheva","year":"2009","journal-title":"Gastroenterol Res Pract"},{"key":"R2-20250806","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.suc.2018.12.006","article-title":"Gallstone disease: cholecystitis, Mirizzi syndrome, Bouveret syndrome, gallstone ileus","volume":"99","author":"Alemi","year":"2019","journal-title":"Surg Clin North Am"},{"key":"R3-20250806","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1111\/j.1572-0241.2006.00645.x","article-title":"Characterization of Bouveret\u2019s syndrome: a comprehensive review of 128 cases","volume":"101","author":"Cappell","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"R5-20250806","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1634\/theoncologist.2014-0120","article-title":"Clinical benefits of above-standard dose of octreotide LAR in patients with neuroendocrine tumors for control of carcinoid syndrome symptoms: a multicenter retrospective chart review study","volume":"19","author":"Strosberg","year":"2014","journal-title":"Oncologist"},{"key":"R6-20250806","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/cncr.11105","article-title":"A 5-decade analysis of 13,715 carcinoid tumors","volume":"97","author":"Modlin","year":"2003","journal-title":"Cancer"},{"key":"R7-20250806","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/1471-2407-14-184","article-title":"Bevacizumab plus octreotide and metronomic capecitabine in patients with metastatic well-to-moderately differentiated neuroendocrine tumors: the XELBEVOCT study","volume":"14","author":"Berruti","year":"2014","journal-title":"BMC Cancer"},{"key":"R8-20250806","doi-asserted-by":"crossref","first-page":"5075","DOI":"10.2147\/DDDT.S84177","article-title":"Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analogues","volume":"9","author":"Wolin","year":"2015","journal-title":"Drug Des Devel Ther"},{"key":"R9-20250806","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/cas.12473","article-title":"Multicenter retrospective analysis of systemic chemotherapy for advanced neuroendocrine carcinoma of the digestive system","volume":"105","author":"Yamaguchi","year":"2014","journal-title":"Cancer Sci"},{"key":"R10-20250806","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ijsu.2020.10.034","article-title":"The SCARE 2020 Guideline: updating Consensus Surgical CAse REport (SCARE) Guidelines","volume":"84","author":"Agha","year":"2020","journal-title":"Int J Surg"},{"key":"R11-20250806","first-page":"69","article-title":"Bouveret\u2019s syndrome: gallstone ileus causing gastric outlet obstruction","volume":"69","author":"Lawther","year":"2000","journal-title":"Ulster Med J"},{"key":"R12-20250806","first-page":"504","article-title":"Bouveret\u2019s syndrome \u2013 a rare presentation of gallstone ileus","volume":"100","author":"Heneghan","year":"2007","journal-title":"Ir Med J"},{"key":"R13-20250806","first-page":"5","article-title":"Gallstone ileus \u2013 still a problem with heart","volume":"3","author":"Beuran","year":"2012","journal-title":"Ann Acad Rom Sci Med Sci"},{"key":"R14-20250806","doi-asserted-by":"crossref","first-page":"163","DOI":"10.4067\/S0034-98872008000200004","article-title":"S\u00edndrome de Bouveret: Resoluci\u00f3n end\u00f3scopica y quir\u00fargica de cuatro casos cl\u00ednicos [Bouveret syndrome: report of four cases]","volume":"136","author":"I\u00f1\u00edguez","year":"2008","journal-title":"Rev Med Chil"},{"key":"R15-20250806","first-page":"839370","article-title":"Bouveret syndrome-the rarest variant of gallstone ileus: a case report and literature review","volume":"2013","author":"Mavroeidis","year":"2013","journal-title":"Case Rep Surg"},{"key":"R16-20250806","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1148\/rg.244035222","article-title":"Bouveret syndrome","volume":"24","author":"Brennan","year":"2004","journal-title":"Radiographics"},{"key":"R17-20250806","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/PL00011935","article-title":"Radiological findings in Bouveret\u2019s syndrome","volume":"8","author":"Trubek","year":"2001","journal-title":"Emerg Radiol"},{"key":"R18-20250806","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.3748\/wjg.v11.i14.2142","article-title":"Value of CT in the diagnosis and management of gallstone ileus","volume":"11","author":"Yu","year":"2005","journal-title":"World J Gastroenterol"},{"key":"R19-20250806","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.2214\/ajr.180.4.1801033","article-title":"Case report. CT, MR cholangiopancreatography, and endoscopy findings in Bouveret\u2019s syndrome","volume":"180","author":"Pickhardt","year":"2003","journal-title":"Am J Roentgenol"},{"key":"R20-20250806","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1665-2681(19)31937-4","article-title":"Bouveret\u2019s syndrome. Narrative review","volume":"6","author":"Koulaouzidis","year":"2007","journal-title":"Ann Hepatol"},{"key":"R21-20250806","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1046\/j.1445-2197.2002.02319.x","article-title":"Bouveret\u2019s syndrome in Melbourne","volume":"72","author":"Liew","year":"2002","journal-title":"ANZ J Surg"},{"key":"R22-20250806","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2482-13-33","article-title":"Bouveret\u2019s syndrome: presentation of two cases with review of the literature and development of a surgical treatment strategy","volume":"13","author":"Nickel","year":"2013","journal-title":"BMC Surg"},{"key":"R23-20250806","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/cam4.435","article-title":"Association of dose escalation of octreotide long-acting release on clinical symptoms and tumor markers and response among patients with neuroendocrine tumors","volume":"4","author":"Al-Efraij","year":"2015","journal-title":"Cancer Med"},{"key":"R24-20250806","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1503\/cjs.007616","article-title":"A population-based study of outcomes in patients with gastrointestinal neuroendocrine tumours","volume":"60","author":"McMullen","year":"2017","journal-title":"Can J Surg"},{"key":"R25-20250806","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.dld.2015.07.155","article-title":"Intermittent treatment of recurrent type-1 gastric carcinoids with somatostatin analogues in patients with chronic autoimmune atrophic gastritis","volume":"47","author":"Massironi","year":"2015","journal-title":"Dig Liver Dis"},{"key":"R26-20250806","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1097\/MPA.0000000000001431","article-title":"Racial differences in the incidence and survival of patients with neuroendocrine tumors","volume":"48","author":"Shen","year":"2019","journal-title":"Pancreas"},{"key":"R27-20250806","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s00535-009-0194-8","article-title":"Epidemiological study of gastroenteropancreatic neuroendocrine tumors in Japan","volume":"45","author":"Ito","year":"2010","journal-title":"J Gastroenterol"},{"key":"R28-20250806","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ecl.2010.12.005","article-title":"The epidemiology of gastroenteropancreatic neuroendocrine tumors","volume":"40","author":"Lawrence","year":"2011","journal-title":"Endocrinol Metab Clin North Am"},{"key":"R30-20250806","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000443168","article-title":"Vienna Consensus Conference participants. ENETS Consensus Guidelines Update for Gastroduodenal Neuroendocrine Neoplasms","volume":"103","author":"Delle Fave","year":"2016","journal-title":"Neuroendocrinology"},{"key":"R31-20250806","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/01.sla.0000167862.52309.7d","article-title":"Gastric carcinoids: biologic behavior and prognosis after differentiated treatment in relation to type","volume":"242","author":"Borch","year":"2005","journal-title":"Ann Surg"},{"key":"R32-20250806","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/jso.20468","article-title":"Presentation, treatment, and outcome of type 1 gastric carcinoid tumors","volume":"93","author":"Dakin","year":"2006","journal-title":"J Surg Oncol"},{"key":"R33-20250806","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s002689900026","article-title":"Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior","volume":"20","author":"Rindi","year":"1996","journal-title":"World J Surg"},{"key":"R34-20250806","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.suc.2016.11.008","article-title":"Neuroendocrine tumors of the stomach","volume":"97","author":"Corey","year":"2017","journal-title":"Surg Clin North Am"},{"key":"R35-20250806","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1097\/00042737-200112000-00008","article-title":"Atrophic body gastritis patients with enterochromaffin-like cell dysplasia are at increased risk for the development of type I gastric carcinoid","volume":"13","author":"Annibale","year":"2001","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R36-20250806","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1111\/j.1365-2036.2011.04659.x","article-title":"Development of type I gastric carcinoid in patients with chronic atrophic gastritis","volume":"33","author":"Vannella","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"R37-20250806","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1530\/EJE-12-0836","article-title":"Long-term follow-up of a large series of patients with type 1 gastric carcinoid tumors: data from a multicenter study","volume":"168","author":"Thomas","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"R38-20250806","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000335595","article-title":"ENETS Consensus Guidelines for the management of patients with gastroduodenal neoplasms","volume":"95","author":"Delle Fave","year":"2012","journal-title":"Neuroendocrinology"},{"key":"R39-20250806","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000329043","article-title":"Type I gastric carcinoids: a prospective study on endoscopic management and recurrence rate","volume":"95","author":"Merola","year":"2012","journal-title":"Neuroendocrinology"},{"key":"R40-20250806","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1007\/s00268-011-1137-0","article-title":"Review of the pathogenesis, diagnosis, and management of type I gastric carcinoid tumor","volume":"35","author":"Zhang","year":"2011","journal-title":"World J Surg"},{"issue":"Pt 1","key":"R41-20250806","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/0016-5085(92)90787-Y","article-title":"Rapid regression of enterochromaffinlike cell gastric carcinoids in pernicious anemia after antrectomy","volume":"102","author":"Hirschowitz","year":"1992","journal-title":"Gastroenterology"},{"key":"R42-20250806","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jss.2010.01.005","article-title":"Laparoscopic antrectomy for the treatment of type I gastric carcinoid tumors","volume":"162","author":"Ozao-Choy","year":"2010","journal-title":"J Surg Res"},{"key":"R43-20250806","doi-asserted-by":"crossref","first-page":"e1748","DOI":"10.1097\/MD.0000000000001748","article-title":"Differing clinical courses and prognoses in patients with gastric neuroendocrine tumors based on the 2010-WHO Classification Scheme","volume":"94","author":"Kim","year":"2015","journal-title":"Medicine (Baltimore)"}],"container-title":["Annals of Medicine &amp; Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000000459","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T13:26:22Z","timestamp":1754486782000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000000459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":41,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/ms9.0000000000000459","relation":{},"ISSN":["2049-0801"],"issn-type":[{"type":"electronic","value":"2049-0801"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"2022-12-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-16","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}